International Society of Antimicrobial Chemotherapy

Featured Video

Vaccines, human challenge studies and impact on AMR

Join ISAC’s Rapid Diagnostics and Biomarkers Working Group for a webinar exploring Vaccines, Human Challenge Studies and Their Impact on AMR. This session brings together leading experts advancing the frontiers of vaccine development through controlled human infection models.

Watch Video

1 month to go: 34th ICC - submit abstracts / apply for travel grants

Manila, Philippines
7 - 9 December 2026
Submit your abstract and apply for Young Investigator Travel awards by 15 June 2026.

Read More

Crimean-Congo Haemorrhagic Fever

Regional Insights and Lessons Learned
20 May, 13.00 CET 

This webinar brings together leading experts to explore the evolving epidemiology, clinical patterns and public health challenges of Crimean- Congo Haemorrhagic Fever (CCHF) in two highly affected regions.

Read More

Living legends podcast series: episode 2

Living Legends in Infectious Diseases is a new podcast series from the International Society of Antimicrobial Chemotherapy (ISAC) celebrating the individuals whose work has shaped modern infectious diseases, antimicrobial stewardship, diagnostics and infection prevention & control.

In this episode Ian Gould interviews Jos van der Meer (Emeritus Professor and former Chairman at the Department of Internal Medicine of the Radboud University Nijmegen Medical Centre in Nijmegen).

Read More

How to get your paper published in IJAA and JGAR

This expert-led webinar, hosted by ISAC and Elsevier, offers practical insights into publishing high quality antimicrobial research.

Read More

Challenges of Antimicrobial Resistances in Different Scenarios

ISAC / symposium at Asia Pacific Congress of Clinical Microbiology and Infections (APCCMI), Bangkok, November 2025

The symposium focused on the global challenge of Antimicrobial Resistance (AMR), highlighting its multifaceted impact in conflict zones, post-pandemic settings, and the One Health perspective involving wildlife.

Read More